Screener
CME Group CME Income Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| $1.71B+0.8% | $1.88B+14.5% | $1.65B+8.1% | $1.54B-3.0% | $1.69B+10.4% | ||
| $599.1M+6.5% | $570.4M+6.8% | $629.1M+8.8% | $565M+0.9% | $562.7M+5.8% | ||
| $1.11B-2.0% | $1.31B+18.2% | $1.02B+7.7% | $972.6M-5.0% | $1.13B+12.9% | ||
| 64.9%-1.9pp | 69.7%+2.2pp | 61.8%-0.3pp | 63.3%-1.4pp | 66.7%+1.5pp | ||
| $43.6M-0.9% | $43.6M+4.6% | $43.7M+7.4% | $44M+9.5% | $44M+9.7% | ||
| $220.6M+9.8% | $201.2M+47.1% | $558.8M+274% | $204.4M+33.9% | $201M+30.6% | ||
| $1.33B-0.2% | $1.51B+21.4% | —— | $1.18B0.0% | $1.33B+15.2% | ||
| $285.9M-6.3% | $356.6M+23.6% | $395.5M+78.2% | $269M+1.9% | $305.2M+12.5% | ||
| $1.04B+2.9% | $1.17B+23.7% | $1.22B+34.3% | $896.6M-0.5% | $1.01B+16.1% | ||
| 61.1%+1.2pp | 62.1%+4.6pp | 73.9%+14.4pp | 58.3%+1.4pp | 59.8%+2.9pp | ||
| $2.88+2.5% | $3.18+21.4% | $3.24+35.0% | $2.49-0.4% | $2.81+16.1% | ||
| $1.19B+3.0% | $1.39B+22.7% | $1.05B+7.2% | $999.48M-5.1% | $1.16B+12.3% | ||
| 69.8%+1.5pp | 74.1%+5.0pp | 63.5%-0.5pp | 65%-1.5pp | 68.3%+1.2pp | ||
| $1.11B-2.0% | $1.31B+18.2% | $1.02B+7.7% | $972.6M-5.0% | $1.13B+12.9% |
FAQ
- What is CME Group's revenue?
- CME Group (CME) generated $6.8B in revenue over the trailing twelve months, up 5.1% year over year.
- Is CME Group profitable?
- CME Group reported $4.3B in net income over the trailing twelve months, a 63.9% net margin.
- What is CME Group's earnings per share?
- CME Group's diluted EPS over the trailing twelve months is $11.79.
- Where does CME Group's income statement data come from?
- Every line is extracted from CME Group's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
